FindMyKOL
Clinical trialNCT00472719CompletedPhase 1Interventional

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment17HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the safety of and immune response to an experimental DNA HIV vaccine followed by boosting with either an experimental adenoviral vector HIV vaccine of serotype 5 or 35 in HIV uninfected adults. This study will also determine the safety of and immune response to an adenoviral vector HIV vaccine of serotype 5 followed by a booster of an adenoviral vector of serotype 35, or vice versa, in HIV uninfected adults.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Jonathan Fuchs, MD, MPH

    San Francisco Department of Public Health, University of California, San Francisco

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Vaccine Crs

    Birmingham, Alabama, United States

  • Bridge Hiv Crs

    San Francisco, California, United States

  • Columbia P&s Crs

    New York, New York, United States

  • New York Blood Center Crs

    New York, New York, United States

  • University of Rochester Vaccines To Prevent Hiv Infection Crs

    Rochester, New York, United States

  • Vanderbilt Vaccine (vv) Crs

    Nashville, Tennessee, United States

  • Seattle Vaccine and Prevention Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

VRC-HIVADV027-00-VPVRC-HIVADV038-00-VPVRC-HIVDNA044-00-VP
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2007
Primary completion
31 Jul 2008
Completion
31 Jan 2013
Last update posted
14 Oct 2021
Registered enrollment
17
Registry id
NCT00472719

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.